Ind-Swift Labs.

{
  "main_header": {
    "sid": 393806,
    "name": "Ind-Swift Labs.",
    "stock_name": "Ind-Swift Labs.",
    "full_name": "Ind-Swift Laboratories Ltd",
    "name_url": "stocks-analysis/ind-swift-labs",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "146.65",
    "chg": 9.25,
    "chgp": "6.73%",
    "dir": 1,
    "prev_price": "137.40",
    "mcapval": "1,142.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 532305,
    "symbol": "INDSWFTLAB",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE915B01019",
    "curr_date": "Mar 17",
    "curr_time": "",
    "bse_nse_vol": "6.4 lacs",
    "exc_status": "Active",
    "traded_date": "Mar 17, 2026",
    "traded_date_str": "2026 03 17",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/ind-swift-labs-393806-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "text": "Part of MojoOne Strategy",
      "type": "MN",
      "url": "https://www.marketsmojo.com/mojopro/strategy/2",
      "ismore": 0,
      "all_data": [],
      "is_blur": 1,
      "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/ind-swift-labs-393806-0&utm_source=Spage_Score_PartofStrategies"
    }
  },
  "news": {
    "results": [
      {
        "title": "Ind-Swift Laboratories Declines 5.67%: Mixed Signals and Downgrade Shape the Week",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ind-swift-laboratories-declines-567-mixed-signals-and-downgrade-shape-the-week-3891989",
        "imagepath": "",
        "date": "2026-03-15 10:01:32",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>2 Mar:</strong> Stock drops 5.78% amid broad market weakness</p>\n                    <p><strong>4 Mar:</strong> Further decline of 8.03% on low volume</p>\n                    <p><strong>5 Mar:</strong> Sharp rebound with 8.93% gain supported by technical momentum</p>\n                    <p><strong>6 Mar:</strong> Downgrade to Sell and mixed technical signals weigh on price, closing near Rs.137.20</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.145.45</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class..."
      },
      {
        "title": "Ind-Swift Laboratories Gains 0.18%: 2 Key Factors Driving the Week",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ind-swift-laboratories-gains-018-2-key-factors-driving-the-week-3891322",
        "imagepath": "",
        "date": "2026-03-14 15:03:05",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>09 Mar:</strong> Mojo grade upgraded to Hold on improved technicals and financial trends</p>\n                    <p><strong>10 Mar:</strong> Bullish momentum confirmed with 3.13% intraday gain closing at Rs.141.50</p>\n                    <p><strong>13 Mar:</strong> Sharp decline of 4.02% amid broader market weakness</p>\n                    <p><strong>Week Summary:</strong> Stock ends at Rs.137.45, outperforming Sensex by 5.05%</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.137.20</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-la..."
      },
      {
        "title": "Ind-Swift Laboratories Ltd Upgraded to Hold by MarketsMOJO on Improved Technicals and Financial Trends",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/ind-swift-laboratories-ltd-upgraded-to-hold-by-marketsmojo-on-improved-technicals-and-financial-trends-3882097",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/IndSwiftLaborat_mojoScore_3882097.png",
        "date": "2026-03-10 08:16:24",
        "description": "Ind-Swift Laboratories Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a notable improvement in its technical indicators and recent financial results. The upgrade, effective from 9 March 2026, is driven by a combination of bullish technical trends, strong quarterly earnings growth, and a more favourable valuation outlook, despite some lingering concerns over long-term fundamentals."
      },
      {
        "title": "Ind-Swift Laboratories Ltd Sees Bullish Momentum Amid Technical Upgrades",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ind-swift-laboratories-ltd-sees-bullish-momentum-amid-technical-upgrades-3881836",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/IndSwiftLaborat_technicaldot_3881836.png",
        "date": "2026-03-10 08:01:31",
        "description": "Ind-Swift Laboratories Ltd has demonstrated a notable shift in price momentum, supported by a series of bullish technical indicators. The pharmaceutical and biotechnology company’s shares have surged 3.13% today, closing at ₹141.50, reflecting renewed investor confidence and a positive outlook following recent technical upgrades."
      },
      {
        "title": "Ind-Swift Laboratories Ltd Downgraded to Sell Amid Mixed Financial and Technical Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/ind-swift-laboratories-ltd-downgraded-to-sell-amid-mixed-financial-and-technical-signals-3875282",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/IndSwiftLaborat_mojoScore_3875282.png",
        "date": "2026-03-06 08:05:32",
        "description": "Ind-Swift Laboratories Ltd has seen its investment rating downgraded from Hold to Sell as of 5 March 2026, reflecting a complex interplay of technical indicators, valuation concerns, financial trends, and quality assessments. Despite recent positive quarterly results and strong stock returns, underlying fundamental weaknesses and mixed technical signals have prompted a cautious stance from analysts."
      },
      {
        "title": "Ind-Swift Laboratories Ltd Technical Momentum Shifts Amid Mixed Indicator Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ind-swift-laboratories-ltd-technical-momentum-shifts-amid-mixed-indicator-signals-3875154",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/IndSwiftLaborat_technicaldot_3875154.png",
        "date": "2026-03-06 08:00:53",
        "description": "Ind-Swift Laboratories Ltd has experienced a notable shift in its technical parameters, reflecting a nuanced change in price momentum. While some indicators signal bullish tendencies, others suggest caution, resulting in a mildly bullish outlook overall. This article analyses the recent technical developments, key indicator readings, and the stock’s performance relative to broader market benchmarks."
      },
      {
        "title": "Ind-Swift Laboratories Ltd is Rated Hold",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/ind-swift-laboratories-ltd-is-rated-hold-3862193",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/IndSwiftLaborat_mojoScore_3862193.png",
        "date": "2026-02-28 10:10:03",
        "description": "Ind-Swift Laboratories Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 05 February 2026. However, all fundamentals, returns, and financial metrics discussed here reflect the stock's current position as of 28 February 2026, providing investors with an up-to-date analysis of the company’s standing."
      },
      {
        "title": "Ind-Swift Laboratories Ltd Hits New 52-Week High at Rs.151.95",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ind-swift-laboratories-ltd-hits-new-52-week-high-at-rs15195-3859725",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/IndSwiftLaborat_priceRelatedfactors_3859725.png",
        "date": "2026-02-27 09:43:27",
        "description": "Ind-Swift Laboratories Ltd has reached a significant milestone by hitting a new 52-week high of Rs.151.95, marking a notable surge in its stock price amid a challenging market environment. This achievement underscores the company’s strong momentum and robust performance over the past year."
      },
      {
        "title": "Ind-Swift Laboratories Ltd Hits New 52-Week High at Rs.148.2",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/ind-swift-laboratories-ltd-hits-new-52-week-high-at-rs1482-3844324",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/IndSwiftLaborat_priceRelatedfactors_3844324.png",
        "date": "2026-02-17 10:36:54",
        "description": "Ind-Swift Laboratories Ltd has surged to a fresh 52-week high, touching Rs.148.2 today, marking a significant milestone in its stock performance amid sustained upward momentum over recent sessions."
      }
    ],
    "total": 177,
    "sid": "393806",
    "stock_news_url": "https://www.marketsmojo.com/news/ind-swift-laboratories-393806"
  },
  "announcements": [
    {
      "caption": "Intimation Regarding Ecovadis Silver Medal And Global Certification",
      "datetime": "02-Mar-2026",
      "details": "Please refer attached pdf.",
      "source": "BSE"
    },
    {
      "caption": "Lapse Of 6500000 Fully Convertible Warrants And Forfeiture Of Upfront Amount",
      "datetime": "01-Mar-2026",
      "details": "Please refer attached pdf.",
      "source": "BSE"
    },
    {
      "caption": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011",
      "datetime": "27-Feb-2026",
      "details": "The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Essix Biosciences Ltd & Others",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Ind-Swift Laboratories Ltd has declared <strong>10%</strong> dividend, ex-date: 20 Sep 11",
          "dt": "2011-09-20",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Ind-Swift Laboratories Declines 5.67%: Mixed Signals and Downgrade Shape the Week

2026-03-15 10:01:32

Key Events This Week

2 Mar: Stock drops 5.78% amid broad market weakness

4 Mar: Further decline of 8.03% on low volume

5 Mar: Sharp rebound with 8.93% gain supported by technical momentum

6 Mar: Downgrade to Sell and mixed technical signals weigh on price, closing near Rs.137.20

Week Open

Rs.145.45

Week Close

Read full news article

Ind-Swift Laboratories Gains 0.18%: 2 Key Factors Driving the Week

2026-03-14 15:03:05

Key Events This Week

09 Mar: Mojo grade upgraded to Hold on improved technicals and financial trends

10 Mar: Bullish momentum confirmed with 3.13% intraday gain closing at Rs.141.50

13 Mar: Sharp decline of 4.02% amid broader market weakness

Week Summary: Stock ends at Rs.137.45, outperforming Sensex by 5.05%

Week Open

Rs.137.20

Read full news article

Ind-Swift Laboratories Ltd Upgraded to Hold by MarketsMOJO on Improved Technicals and Financial Trends

2026-03-10 08:16:24

Ind-Swift Laboratories Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a notable improvement in its technical indicators and recent financial results. The upgrade, effective from 9 March 2026, is driven by a combination of bullish technical trends, strong quarterly earnings growth, and a more favourable valuation outlook, despite some lingering concerns over long-term fundamentals.

Read full news article

Ind-Swift Laboratories Ltd Sees Bullish Momentum Amid Technical Upgrades

2026-03-10 08:01:31

Ind-Swift Laboratories Ltd has demonstrated a notable shift in price momentum, supported by a series of bullish technical indicators. The pharmaceutical and biotechnology company’s shares have surged 3.13% today, closing at ₹141.50, reflecting renewed investor confidence and a positive outlook following recent technical upgrades.

Read full news article

Ind-Swift Laboratories Ltd Downgraded to Sell Amid Mixed Financial and Technical Signals

2026-03-06 08:05:32

Ind-Swift Laboratories Ltd has seen its investment rating downgraded from Hold to Sell as of 5 March 2026, reflecting a complex interplay of technical indicators, valuation concerns, financial trends, and quality assessments. Despite recent positive quarterly results and strong stock returns, underlying fundamental weaknesses and mixed technical signals have prompted a cautious stance from analysts.

Read full news article

Ind-Swift Laboratories Ltd Technical Momentum Shifts Amid Mixed Indicator Signals

2026-03-06 08:00:53

Ind-Swift Laboratories Ltd has experienced a notable shift in its technical parameters, reflecting a nuanced change in price momentum. While some indicators signal bullish tendencies, others suggest caution, resulting in a mildly bullish outlook overall. This article analyses the recent technical developments, key indicator readings, and the stock’s performance relative to broader market benchmarks.

Read full news article

Ind-Swift Laboratories Ltd is Rated Hold

2026-02-28 10:10:03

Ind-Swift Laboratories Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 05 February 2026. However, all fundamentals, returns, and financial metrics discussed here reflect the stock's current position as of 28 February 2026, providing investors with an up-to-date analysis of the company’s standing.

Read full news article

Ind-Swift Laboratories Ltd Hits New 52-Week High at Rs.151.95

2026-02-27 09:43:27

Ind-Swift Laboratories Ltd has reached a significant milestone by hitting a new 52-week high of Rs.151.95, marking a notable surge in its stock price amid a challenging market environment. This achievement underscores the company’s strong momentum and robust performance over the past year.

Read full news article

Ind-Swift Laboratories Ltd Hits New 52-Week High at Rs.148.2

2026-02-17 10:36:54

Ind-Swift Laboratories Ltd has surged to a fresh 52-week high, touching Rs.148.2 today, marking a significant milestone in its stock performance amid sustained upward momentum over recent sessions.

Read full news article

View All News